Chardan Healthcare Acquisition 2 Corp.

Ready to reinvent healthcare.

Renovacor, Inc. to Merge with Chardan Healthcare Acquisition 2 Corp.

Read More
Renovacor Corporate Presentation

Renovacor, Inc. Announces the Appointment of Matt Killeen, PhD, as Chief Scientific Officer.

Read More

A $85 million SPAC seeks to acquire a healthcare company.

Led by an experienced management team, Chardan Healthcare Acquisition 2 Corp. is looking to partner with the next disruptive healthcare company to take public. Chardan leads the effort in using the power of a special purpose acquisition company (SPAC) to bring innovative healthcare ventures to public investors.


Our investment criteria.

  • Funded Healthcare Company

    Venture-backed healthcare company in the biopharma sector

  • Well Managed

    Experienced management team with proven public company success

  • IPO Ready

    Actively considering public listing

  • Valuation Range

    $250M+ IPO valuation

  • Post Deal Upside

    Upcoming catalysts to drive valuation post business combinations

Contact us for more information about CHAQ.U or Chardan's SPAC practice.

Get in touch

Meet our experienced management team.

  • Gbola Amusa, MD, CFA

    Executive Chairman and Chief Science Officer

  • Jonas Grossman

    President, CEO and Director

  • George Kaufman

    CFO, Head of Strategy and Director

  • Guy Barudin


Leveraging Chardan post business combination.

  • Equity Intelligence Platform

    A track record of communicating alpha-generative ideas to investors seeking exceptional returns and strong relationships with syndicate partners.

  • Corporate Access

    Proprietary access to fundamental buyside investors via NDRs, conferences and KOL events, plus a large geographical investor outreach including both U.S. and Europe.

  • Pharma Relationships

    Meaningful connections with large pharma for near-term M&A idea generation and opportunities.

  • Academic & Research Institution Relationships

    Extensive relationships with leading academic and research institutions to source and support the advancement of groundbreaking healthcare technologies.

Thank You!

We've received your information, and we're processing your request.

Get In Touch

17 State Street
Suite 2100
New York, NY 10004

+1 646-465-9001

Contact Us